LIR Life Sciences Corp. (CSE:SKNY)
1.900
-0.450 (-19.15%)
At close: Jan 13, 2026
322.22% (1Y)
| Market Cap | 52.95M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -566.64K |
| Shares Out | 27.87M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 265,733 |
| Average Volume | 139,599 |
| Open | 2.360 |
| Previous Close | 2.350 |
| Day's Range | 1.500 - 2.370 |
| 52-Week Range | 0.450 - 2.410 |
| Beta | n/a |
| RSI | 55.99 |
| Earnings Date | Mar 31, 2026 |